These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1007 related articles for article (PubMed ID: 27053091)
1. Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial. Yang F; Sui X; Chen X; Zhang L; Wang X; Wang S; Wang J Trials; 2016 Apr; 17():191. PubMed ID: 27053091 [TBL] [Abstract][Full Text] [Related]
2. Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer. Okami J; Ito Y; Higashiyama M; Nakayama T; Tokunaga T; Maeda J; Kodama K Ann Thorac Surg; 2010 Nov; 90(5):1651-6. PubMed ID: 20971281 [TBL] [Abstract][Full Text] [Related]
3. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI; J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection. Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779 [TBL] [Abstract][Full Text] [Related]
6. Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients? Chamogeorgakis T; Ieromonachos C; Georgiannakis E; Mallios D Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):364-72. PubMed ID: 18641014 [TBL] [Abstract][Full Text] [Related]
7. Sublobar resection versus lobectomy for stage I non-small cell lung cancer: an appropriate choice in elderly patients? Fiorelli A; Caronia FP; Daddi N; Loizzi D; Ampollini L; Ardò N; Ventura L; Carbognani P; Potenza R; Ardissone F; Sollitto F; Mattioli S; Puma F; Santini M; Ragusa M Surg Today; 2016 Dec; 46(12):1370-1382. PubMed ID: 27085869 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of lobar and sublobar resections for non-small-cell lung cancer: a single-center experience. Kim D; Ferraris VA; Davenport D; Saha S South Med J; 2015 Apr; 108(4):230-4. PubMed ID: 25871994 [TBL] [Abstract][Full Text] [Related]
9. Sublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a Surveillance, Epidemiology, and End Results database analysis. Razi SS; John MM; Sainathan S; Stavropoulos C J Surg Res; 2016 Feb; 200(2):683-9. PubMed ID: 26490227 [TBL] [Abstract][Full Text] [Related]
10. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis. Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study. Ayub A; Rehmani SS; Al-Ayoubi AM; Raad W; Flores RM; Bhora FY Ann Thorac Surg; 2017 Oct; 104(4):1131-1137. PubMed ID: 28709663 [TBL] [Abstract][Full Text] [Related]
12. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Wolf AS; Richards WG; Jaklitsch MT; Gill R; Chirieac LR; Colson YL; Mohiuddin K; Mentzer SJ; Bueno R; Sugarbaker DJ; Swanson SJ Ann Thorac Surg; 2011 Nov; 92(5):1819-23; discussion 1824-5. PubMed ID: 22051277 [TBL] [Abstract][Full Text] [Related]
13. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer. Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323 [TBL] [Abstract][Full Text] [Related]
14. Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer. Birdas TJ; Koehler RP; Colonias A; Trombetta M; Maley RH; Landreneau RJ; Keenan RJ Ann Thorac Surg; 2006 Feb; 81(2):434-8; discussion 438-9. PubMed ID: 16427827 [TBL] [Abstract][Full Text] [Related]
15. Long term outcomes after lobar versus sublobar resection for patients with Non-Small cell lung Cancer: Systematic review and individual patient data Meta-Analysis. Tasoudis P; Loufopoulos G; Manaki V; Doerr M; Agala CB; Long JM; Haithcock BE Lung Cancer; 2024 Sep; 195():107929. PubMed ID: 39173232 [TBL] [Abstract][Full Text] [Related]
16. A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer. Gulack BC; Yang CJ; Speicher PJ; Yerokun BA; Tong BC; Onaitis MW; D'Amico TA; Harpole DH; Hartwig MG; Berry MF Ann Thorac Surg; 2016 Dec; 102(6):1814-1820. PubMed ID: 27592602 [TBL] [Abstract][Full Text] [Related]
17. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm. Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690 [TBL] [Abstract][Full Text] [Related]
18. Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer. Lv X; Cao J; Dai X; Rusidanmu A Thorac Cancer; 2018 Aug; 9(8):1026-1031. PubMed ID: 29927089 [TBL] [Abstract][Full Text] [Related]
19. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion. Moon Y; Lee KY; Park JK World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091 [TBL] [Abstract][Full Text] [Related]
20. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Altorki NK; Wang X; Wigle D; Gu L; Darling G; Ashrafi AS; Landrenau R; Miller D; Liberman M; Jones DR; Keenan R; Conti M; Wright G; Veit LJ; Ramalingam SS; Kamel M; Pass HI; Mitchell JD; Stinchcombe T; Vokes E; Kohman LJ Lancet Respir Med; 2018 Dec; 6(12):915-924. PubMed ID: 30442588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]